Sepsis AI: From Alert Fatigue to Platform Power
AI’s first wave in healthcare crashed against the hard reality of clinical practice. Sepsis prediction models were the…
Beyond 510(k): De-Risking AI for Clinical & Investment Wins
AI in diagnostic imaging isn’t just a promise anymore. It’s a reality that’s supposed to deliver faster read…
EHRs Dominate Clinical Generative AI: Why Platforms Win
Generative AI is a big deal in healthcare, but for VCs and health system CIOs, the real question…
AI Health: Measuring Engagement for Investor ROI
While the buzz around AI in healthcare usually focuses on big clinical breakthroughs, investors looking for real ROI…
Cardiac AI: The Companies Reducing Risk & Driving Returns
Cardiac care is flipping from a reactive model to a proactive one, and machine learning is what’s driving…
Investing in Stroke AI: Vendors Proving Clinical Efficacy Now
Using AI to cut down stroke risk is a complex job. It needs to detect the problem fast,…
Cardiac AI: Unlocking Billion-Dollar Outcomes Through Interoperability
Using AI to cut heart attack risk is a great story for investors. The real work, though, isn’t…
Venture-Grade AI: Investing in Cardiovascular Health Outcomes
The promise of AI in healthcare isn’t some abstract future. It’s the ability to spot a stroke on…
Cardiac AI: Scaling Outcomes for Investor Returns
Scalability for cardiovascular AI boils down to two things: clinical precision and smooth enterprise integration. If you’re an…
Cardiac AI: Validated Outcomes Drive Investor Value
When you’re an investor trying to sort through the cardiovascular AI space, you have to cut through the…